How do host restriction factors influence dengue virus replication?
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Future Medicine Ltd.
2016
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 06354caa a22007337a 4500 | ||
|---|---|---|---|
| 001 | PAPER-15499 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230607132234.0 | ||
| 008 | 190411s2016 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-85003026991 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 100 | 1 | |a Giovannoni, F. | |
| 245 | 1 | 4 | |a How do host restriction factors influence dengue virus replication? |
| 260 | |b Future Medicine Ltd. |c 2016 | ||
| 270 | 1 | 0 | |m García, C.C.; Departamento de Química Biológica (QB), Laboratorio de Estrategias Antivirales, Facultad de Ciencias Exactas y Naturales (FCEyN), Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET)Argentina; email: cygarcia@qb.fcen.uba.ar |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Bieniasz, P.D., Restriction factors: A defense against retroviral infection (2003) Trends Microbiol., 11 (6), pp. 286-291 | ||
| 504 | |a Wang, X., Hinson, E.R., Cresswell, P., The interferon-inducible protein viperin inhibits infuenza virus release by perturbing lipid rafts (2007) Cell Host Microbe, 2, pp. 96-105 | ||
| 504 | |a Seo, J.Y., Yaneva, R., Hinson, E.R., Cresswell, P., Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity (2011) Science, 332, pp. 1093-1097 | ||
| 504 | |a Lazear, H.M., Diamond, M.S., New insights into innate immune restriction of west nile virus infection (2015) Curr. Opin. Virol., 11, pp. 1-6 | ||
| 504 | |a Zhou, L.Y., Zhang, L.L., Host restriction factors for hepatitis C virus (2016) World J. Gastroenterol., 22 (4), pp. 1477-1486 | ||
| 504 | |a Pan, X.B., Han, J.C., Cong, X., Wei, L., BST2/ tetherin inhibits dengue virus release from human hepatoma cells (2012) PLoS ONE, 7 (12), p. e51033 | ||
| 504 | |a Stetson, D.B., Medzhitov, R., Type 1 interferons in host defense (2006) Immunity, 25 (3), pp. 373-381 | ||
| 504 | |a Fink, J., Gu, F., Ling, L., Host gene expression profling of dengue virus infection in cell lines and patients (2007) PLoS Negl. Trop. Dis., 1 (2), p. e86 | ||
| 504 | |a Jiang, D., Weidner, J.M., Qing, M., Identifcation of fve interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections (2010) J. Virol., 84, pp. 8332-8341 | ||
| 504 | |a Brass, A.L., Huang, I.C., Benita, Y., The IFITM proteins mediate cellular resistance to infuenza A H1N1 virus, West Nile virus, and dengue virus (2009) Cell, 139, pp. 1243-1254 | ||
| 504 | |a Lu, M.Y., Liao, F., Interferon-stimulated gene ISG12b2 is localized to the inner mitochondrial membrane and mediates virus-induced cell death (2011) Cell Death Differ., 18, pp. 925-936 | ||
| 504 | |a Dai, J., Pan, W., Wang, P., ISG15 facilitates cellular antiviral response to dengue and West Nile virus infection in vitro (2011) Virol. J., 8, p. 468 | ||
| 504 | |a Tay, M.Y., Fraser, J.E., Chan, W.K., Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; Protection against all 4 DENV serotypes by the inhibitor ivermectin (2013) Antiviral Res., 99 (3), pp. 301-306 | ||
| 504 | |a Sangiambut, S., Keelapang, P., Aaskov, J., Multiple regions in dengue virus capsid protein contribute to nuclear localization during virus infection (2008) J. Gen. Virol., 89, pp. 1254-1264 | ||
| 504 | |a De Maio, F.A., Risso, G., Iglesias, N.G., The dengue virus NS5 protein intrudes in the cellular spliceosome and modulates splicing (2016) PLoS Pathog., 12 (8), p. e1005841 | ||
| 504 | |a Hannemann, H., Sung, P.Y., Chiu, H.C., Serotype-specifc differences in dengue virus non-structural protein 5 nuclear localization (2013) J. Biol. Chem., 288, pp. 22621-22635 | ||
| 504 | |a Van Damme, E., Laukens, K., Dang, T.H., Van Ostade, X., A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics (2010) Int. J. Biol. Sci., 6, pp. 51-67 | ||
| 504 | |a Giovannoni, F., Damonte, E.B., García, C.C., Cellular promyelocytic leukemia protein is an important dengue virus restriction factor (2015) PLoS ONE, 10 (5), p. e0125690 | ||
| 504 | |a Chiu, M.W., Shih, H.M., Yang, T.H., Yang, Y.L., The type 2 dengue virus envelope protein interacts with small ubiquitin-like modifer-1 (SUMO-1) conjugating enzyme 9 (Ubc9) (2007) J. Biomed. Sci., 14 (3), pp. 429-444 | ||
| 504 | |a Su, C.I., Tseng, C.H., Yu, C.Y., Lai, M.M., SUMO modifcation stabilizes dengue virus nonstructural protein 5 to support virus replication (2016) J. Virol., 90 (9), pp. 4308-4319 | ||
| 593 | |a Departamento de Química Biológica (QB), Laboratorio de Estrategias Antivirales, Facultad de Ciencias Exactas y Naturales (FCEyN), Instituto de Química Biológica de la Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires (UBA), Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina | ||
| 593 | |a Leibniz Institute on Aging - Fritz-Lipman-Institut, Jena, Germany | ||
| 690 | 1 | 0 | |a DENGUE VIRUS |
| 690 | 1 | 0 | |a HOST FACTORS |
| 690 | 1 | 0 | |a RESTRICTION FACTORS |
| 690 | 1 | 0 | |a HOST FACTOR |
| 690 | 1 | 0 | |a DENGUE |
| 690 | 1 | 0 | |a DENGUE VIRUS |
| 690 | 1 | 0 | |a HOST PATHOGEN INTERACTION |
| 690 | 1 | 0 | |a INTRINSIC ACTIVITY |
| 690 | 1 | 0 | |a LIFE CYCLE |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a NOTE |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a VIROGENESIS |
| 690 | 1 | 0 | |a VIRUS GENOME |
| 690 | 1 | 0 | |a VIRUS MORPHOGENESIS |
| 690 | 1 | 0 | |a VIRUS REPLICATION |
| 700 | 1 | |a Hemmerich, P. | |
| 700 | 1 | |a García, C.C. | |
| 773 | 0 | |d Future Medicine Ltd., 2016 |g v. 11 |h pp. 757-760 |k n. 12 |p Future Virol. |x 17460794 |t Future Virology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-85003026991&doi=10.2217%2ffvl-2016-0095&partnerID=40&md5=700686de619a7a98b04f553122a1fa71 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.2217/fvl-2016-0095 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_17460794_v11_n12_p757_Giovannoni |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_17460794_v11_n12_p757_Giovannoni |y Registro en la Biblioteca Digital |
| 961 | |a paper_17460794_v11_n12_p757_Giovannoni |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 76452 | ||